Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.468 USD | +1.21% | -0.17% | +35.88% |
Mar. 07 | Earnings Flash (IDXG) INTERPACE BIOSCIENCES Reports Q4 Revenue $10.3M | MT |
Mar. 07 | Interpace Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Financials (USD)
Sales 2022 | 31.84M | Sales 2023 | 40.21M | Capitalization | 4.69M |
---|---|---|---|---|---|
Net income 2022 | -22M | Net income 2023 | - | EV / Sales 2022 | 0.49 x |
Net Debt 2022 | 11.26M | Net Debt 2023 | 7.69M | EV / Sales 2023 | 0.31 x |
P/E ratio 2022 |
-0.2
x | P/E ratio 2023 |
6.03
x | Employees | 108 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 72.42% |
1 day | +1.21% | ||
1 week | -0.17% | ||
Current month | -2.17% | ||
1 month | -9.41% | ||
3 months | +39.76% | ||
6 months | +57.80% | ||
Current year | +35.88% |
Managers | Title | Age | Since |
---|---|---|---|
Thomas Burnell
CEO | Chief Executive Officer | 62 | 20-11-30 |
Director of Finance/CFO | 32 | 19-05-31 | |
Nicole Massoll
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Vijay Aggarwal
BRD | Director/Board Member | 75 | 22-01-31 |
Joseph Keegan
BRD | Director/Board Member | 71 | 15-12-31 |
Stephen Sullivan
BRD | Director/Board Member | 77 | 04-08-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 1.468 | +1.21% | 4,751 |
24-04-22 | 1.45 | 0.00% | 860 |
24-04-19 | 1.45 | -1.36% | 6,513 |
24-04-16 | 1.47 | 0.00% | 9,381 |
Delayed Quote OTC Markets, April 23, 2024 at 01:03 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+35.88% | 6.41M | |
-17.98% | 5.25B | |
-6.20% | 1.17B |
- Stock Market
- Equities
- IDXG Stock